Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1.8 million participants

被引:780
作者
Lu, Yuan [1 ]
Hajifathalian, Kaveh [1 ]
Ezzati, Majid [2 ]
Woodward, Mark [3 ]
Rimm, Eric B. [4 ]
Danaei, Goodarz [1 ,5 ]
机构
[1] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA
[2] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, MRC PHE Ctr Environm & Hlth, London, England
[3] George Inst Global Hlth, Sydney, NSW, Australia
[4] Harvard Univ, Sch Med, Brigham & Womens Hosp, Channing Div Network Med, Boston, MA 02115 USA
[5] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
基金
英国医学研究理事会;
关键词
ALL-CAUSE MORTALITY; CARDIOVASCULAR-DISEASE; BLOOD-PRESSURE; RISK-FACTORS; WEIGHT-LOSS; NONCOMMUNICABLE DISEASES; SCIENTIFIC STATEMENT; SYSTEMATIC ANALYSIS; PHYSICAL-ACTIVITY; GLOBAL TRENDS;
D O I
10.1016/S0140-6736(13)61836-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Body-mass index (BMI) and diabetes have increased worldwide, whereas global average blood pressure and cholesterol have decreased or remained unchanged in the past three decades. We quantified how much of the effects of BMI on coronary heart disease and stroke are mediated through blood pressure, cholesterol, and glucose, and how much is independent of these factors. Methods We pooled data from 97 prospective cohort studies that collectively enrolled 1.8 million participants between 1948 and 2005, and that included 57 161 coronary heart disease and 31 093 stroke events. For each cohort we excluded participants who were younger than 18 years, had a BMI of lower than 20 kg/m(2), or who had a history of coronary heart disease or stroke. We estimated the hazard ratio (HR) of BMI on coronary heart disease and stroke with and without adjustment for all possible combinations of blood pressure, cholesterol, and glucose. We pooled HRs with a random-effects model and calculated the attenuation of excess risk after adjustment for mediators. Findings The HR for each 5 kg/m(2) higher BMI was 1.27 (95% CI 1.23-1.31) for coronary heart disease and 1.18 (1.14-1.22) for stroke after adjustment for confounders. Additional adjustment for the three metabolic risk factors reduced the HRs to 1.15 (1.12-1.18) for coronary heart disease and 1.04 (1.01-1.08) for stroke, suggesting that 46% (95% CI 42-50) of the excess risk of BMI for coronary heart disease and 76% (65-91) for stroke is mediated by these factors. Blood pressure was the most important mediator, accounting for 31% (28-35) of the excess risk for coronary heart disease and 65% (56-75) for stroke. The percentage excess risks mediated by these three mediators did not differ significantly between Asian and western cohorts (North America, western Europe, Australia, and New Zealand). Both overweight (BMI >= 25 to < 30 kg/m(2)) and obesity (BMI >= 30 kg/m(2)) were associated with a significantly increased risk of coronary heart disease and stroke, compared with normal weight (BMI >= 20 to < 25 kg/m(2)), with 50% (44-58) of the excess risk of overweight and 44% (41-48) of the excess risk of obesity for coronary heart disease mediated by the selected three mediators. The percentages for stroke were 98% (69-155) for overweight and 69% (64-77) for obesity. Interpretation Interventions that reduce high blood pressure, cholesterol, and glucose might address about half of excess risk of coronary heart disease and three-quarters of excess risk of stroke associated with high BMI. Maintenance of optimum bodyweight is needed for the full benefits.
引用
收藏
页码:970 / 983
页数:14
相关论文
共 54 条
  • [41] Long term pharmacotherapy for obesity and overweight: updated meta-analysis
    Rucker, Diana
    Padwal, Raj
    Li, Stephanie K.
    Curioni, Cintia
    Lau, David C. W.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2007, 335 (7631): : 1194 - 1199
  • [42] Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet.
    Sacks, FM
    Svetkey, LP
    Vollmer, WM
    Appel, LJ
    Bray, GA
    Harsha, D
    Obarzanek, E
    Conlin, PR
    Miller, ER
    Simons-Morton, DG
    Karanja, N
    Lin, PH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (01) : 3 - 10
  • [43] Dietary Therapy in Hypertension
    Sacks, Frank M.
    Campos, Hannia
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (22) : 2102 - 2112
  • [44] Singh GM, The age- specifi c quantitative
  • [45] Effects of bariatric surgery on mortality in Swedish obese subjects
    Sjostrom, Lars
    Narbro, Kristina
    Sjostrom, David
    Karason, Kristjan
    Larsson, Bo
    Wedel, Hans
    Lystig, Ted
    Sullivan, Marianne
    Bouchard, Claude
    Carlsson, Bjorn
    Bengtsson, Calle
    Dahlgren, Sven
    Gummesson, Anders
    Jacobson, Peter
    Karlsson, Jan
    Lindroos, Anna-Karin
    Lonroth, Hans
    Naslund, Ingmar
    Olbers, Torsten
    Stenlof, Kaj
    Torgerson, Jarl
    Agren, Goran
    Carlsson, Lena M. S.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (08) : 741 - 752
  • [46] National, regional, and global trends in adult overweight and obesity prevalences
    Stevens, Gretchen A.
    Singh, Gitanjali M.
    Lu, Yuan
    Danaei, Goodarz
    Lin, John K.
    Finucane, Mariel M.
    Bahalim, Adil N.
    McIntire, Russell K.
    Gutierrez, Hialy R.
    Cowan, Melanie
    Paciorek, Christopher J.
    Farzadfar, Farshad
    Riley, Leanne
    Ezzati, Majid
    [J]. POPULATION HEALTH METRICS, 2012, 10
  • [47] Mechanisms linking obesity with cardiovascular disease
    Van Gaal, Luc F.
    Mertens, Ilse L.
    De Block, Christophe E.
    [J]. NATURE, 2006, 444 (7121) : 875 - 880
  • [48] Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies
    Whitlock, Gary
    Lewington, Sarah
    Sherliker, Paul
    Clarke, Robert
    Emberson, Jonathan
    Halsey, Jim
    Qizilbash, Nawab
    Collins, Rory
    Peto, Richard
    Lewington, S.
    MacMahon, S.
    Peto, R.
    Aromaa, A.
    Baigent, C.
    Carstensen, J.
    Chen, Z.
    Clarke, R.
    Collins, R.
    Duffy, S.
    Kromhout, D.
    Neaton, J.
    Qizilbash, N.
    Rodgers, A.
    Tominaga, S.
    Toernberg, S.
    Tunstall-Pedoe, H.
    Whitlock, G.
    Chambless, L.
    De Backer, G.
    De Bacquer, D.
    Kornitzer, M.
    Whincup, P.
    Wannamethee, S. G.
    Morris, R.
    Wald, N.
    Morris, J.
    Law, M.
    Knuiman, M.
    Bartholomew, H.
    Smith, G. Davey
    Sweetnam, P.
    Elwood, P.
    Yarnell, J.
    Kronmal, R.
    Kromhout, D.
    Sutherland, S.
    Keil, J.
    Jensen, G.
    Schnohr, P.
    Hames, C.
    [J]. LANCET, 2009, 373 (9669) : 1083 - 1096
  • [49] Willett WC, 2013, JAMA-J AM MED ASSOC, V309, P1681, DOI 10.1001/jama.2013.3075
  • [50] Willett WC, 2005, JAMA-J AM MED ASSOC, V294, P551, DOI 10.1001/jama.294.5.551-a